Reports

Drug name	NICE TAs	Comments
Oxytocin
Ozanimod (Zeposia®)	TA828 - Ozanimod for treating moderately to severely active ulcerative colitis
Ozanimod (Zeposia®)	TA828: Ozanimod for treating moderately to severely active ulcerative colitis
Pabrinex injection
Paclitaxel	TA55 - Guidance on the use of paclitaxel in the treatment of ovarian cancer TA91 - Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer
Paclitaxel injection	TA214 - Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer TA284 - Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer	Negative TA
Palbociclib (Ibrance®)	TA495 - Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer TA619 - Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer TA836: Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Palforzia®	Palforzia for treating peanut allergy in children and young people (TA769)
Palifermin injection		Private patients only
Paliperidone (Byannli®)		6 monthly injection

University Hospitals Birmingham NHS Foundation Trust